Skip to main content
OpenTrials

Clinical trial condition

Graves Ophthalmopathy

Explore clinical trials studying Graves Ophthalmopathy. Study availability and eligibility vary by location and protocol.

33 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Graves Ophthalmopathy trial results

Enrolling by invitation

Multi-center Prospective Clinical Study on Glucocorticoid Pulse Therapy for Graves' Ophthalmopathy (GO)

NCT06693856

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +11 more
Locations
  • Shanghai Changzhen Hospital Shanghai, Shanghai Municipality, China
  • Shanghai Changhai Hospital Shanghai, Shanghai Municipality, China
  • Shanghai Longhua Hospital Shanghai, Shanghai Municipality, China
View Trial Details
Completed

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

NCT05276063

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +20 more
Locations
  • Thrive Health Research Beverly Hills, California, United States
  • UC San Diego Health La Jolla, California, United States
  • UCLA Los Angeles, California, United States
  • Byers Eye Institute - Stanford University Palo Alto, California, United States
View all 30 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

NCT06226545

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +15 more
Locations
  • Site 111 Beverly Hills, California, United States
  • Site 105 Palo Alto, California, United States
  • Site 101 San Diego, California, United States
  • Site 103 Miami, Florida, United States
View all 15 locations
View Trial Details

Related conditions